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Background: Endoplasmic reticulum (ER) stress induces ER expansion. The expansion of the intracisternal space of
the ER was found in macrophages associated with human atherosclerotic lesions. We also previously reported that
palmitate induces cisternal ER expansion and necrosis in RAW 264.7 cells. In this study, we report on an
investigation of the likely mechanism responsible for this palmitate-induced cisternal ER expansion in a mouse
macrophage cell line, RAW 264.7 cells.
Methods: RAW 264.7 cells were pre-treated with the designated inhibitor or siRNA, followed by treatment with
palmitate. Changes in the ER structure were examined by transmission electron microscopy. The induction of ER
stress was confirmed by an increase in the extent of phosphorylation of PERK, the expression of BiP and CHOP, and
the splicing of XBP-1 mRNA. Phospholipid staining was performed with the LipidTOX Red phospholipidosis
detection reagent. Related gene expressions were detected by quantitative real time-RT-PCR or RT-PCR.
Results: Palmitate was found to induce ER stress and cisternal ER expansion. In addition, palmitate-induced
cisternal ER expansion was attenuated by ER stress inhibitors, such as 4-phenylbutyric acid (4-PBA) and
tauroursodeoxycholic acid (TUDCA). The findings also show that palmitate induced-mRNA expression of
CCTα, which increases phospholipid synthesis, was attenuated by the down-regulation of XBP-1, a part of
ER stress. Furthermore, palmitate-induced phospholipid accumulation and cisternal ER expansion were
attenuated by the down-regulation of XBP-1 or CCTα.
Conclusions: The findings reported herein indicate that palmitate-induced cisternal ER expansion is
dependent on the activation of XBP-1/CCTα-mediated phospholipid accumulation in RAW 264.7 cells.
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Elevated serum free fatty acids (FFAs) in patients with
obesity and type 2 diabetes inappropriately accumulate
in non-adipose tissue, leading to cellular dysfunction
and cell death [1]. Of the various FFAs, palmitate
(C16:0) is one of the most abundant saturated fatty
acids in plasma [2] and has been reported to be toxic to
cardiomyocytes [3] and macrophages [4].
Palmitate has been reported to induce the production of
intracellular reactive oxygen species (ROS) generation,* Correspondence: sblee@catholic.ac.kr; guetae@catholic.ac.kr
Institute of Hansen’s Disease, Department of Pathology, College of Medicine,
The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul
137-701, Republic of Korea
© 2015 Kim et al. This is an Open Access artic
(http://creativecommons.org/licenses/by/4.0),
provided the original work is properly credited
creativecommons.org/publicdomain/zero/1.0/which subsequently leads to endoplasmic reticulum (ER)
stress and ER expansion in BRIN-BD11 pancreatic β-cells
and C2C12 myoblasts [5, 6]. We have also previously re-
ported that palmitate induces cisternal ER expansion in
mouse macrophage cell line, RAW 264.7 cells [7]. How-
ever, the mechanism of how palmitate induces ER expan-
sion is uncertain in macrophages.
ER stress is one of features shown in lipid-laden mac-
rophages of atherosclerotic plaques [8–10]. ER stress is
generally thought to induce ER expansion via unfolded
protein response (UPR)-mediated lipid biosynthesis and
the subsequent enlargement of the ER, which, in turn,
alleviates ER stress [11].le distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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mRNA splicing which then modifies the X-box binding
protein (XBP)-1 transcript, resulting in the expression of
the transcription factor, XBP-1(S) [12, 13]. XBP-1(S) is a
functionally active transcription factor, whereas the iso-
form XBP-1(U), encoded by the unspliced mRNA, is de-
void of transcriptional activity [14, 15]. In turn, the XBP-
1(S) leads an enhancement in the activities of choline
cytidylyltransferase (CCT) α and choline phosphotrans-
ferase (CPT), thereby increasing the synthesis of phos-
phatidylcholine (PtdCho), the primary phospholipid of
the ER membrane, subsequently leading to ER biogen-
esis or expansion in NIH-3T3 fibroblasts [12, 13]. Thus,
we hypothesized that palmitate-induced cisternal ER ex-
pansion may be mediated by XBP-1/CCTα-mediated
phospholipid accumulation in macrophages.
The purpose of this study was to investigate the mech-
anism responsible for the palmitate-induced cisternal ERFig. 1 Palmitate induces necrosis in RAW 264.7 cells. Cells were treated wit
for 24 h. Changes in ER structure were examined by transmission electron
dye (APOPercentage™ kit, Biocolor, Belfast, NIreland) for 1 h (b) and, by ann
cytometry (c)expansion in RAW 264.7 cells. We initially examined
the issue of whether palmitate-induced ER expansion is
dependent on ER stress. We also assessed whether
palmitate-induced cisternal ER expansion is dependent
on the activation of XBP-1/CCTα-mediated phospho-
lipid accumulation.
Results
Palmitate induces cisternal ER expansion in RAW 264.7
cells
We previously reported that treatment with palmitate
induced necrotic cell death [7]. As shown in Fig. 1a, cells
that had been treated with 400 μΜ palmitate mainly
showed necrotic characteristics, including a loss of
plasma membrane integrity and intracellular vesicle
swelling. We also evaluated the apoptotic activity of
palmitate by measuring the uptake of APOPercentage dye
(red, APOPercentage™ apoptosis assay kit). Staurosporine,h palmitate at the indicated concentration or 4 μM staurosporine
microscopy (a). The treated cells were stained with the APOPercentage
exin V-FITC/propidium iodide (PI) and were analyzed by flow
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trol for apoptosis. The palmitate-treated cells showed a
similar level of APOPercentage dye uptake compared to
control cells, whereas staurosporine-treated cells showed
a higher level of APOPercentage dye uptake than control
cells (Fig. 1b). Furthermore, the palmitate-treated cells
showed a 34.4 % labeling of PI and minimal labeling of
annexin V (Fig. 1c).
Interestingly, ER expansion was frequently found in
cells that survive exposure to palmitate (Figs. 1a and 2).
ER expansion was first observed at 4 h after the palmi-
tate treatment and the extent of ER expansion was
gradually increased in a dose- and a time-dependent
manner in palmitate-treated cells (Fig. 2a and b). In
addition, Calnexin, an ER lectin that mediates protein
folding on the rough ER [16], was localized on the
membrane of cisternal expanded ER (Fig. 2c). TheseFig. 2 Palmitate induces cisternal ER expansion in RAW 264.7 cells. Cells we
and with 400 μM palmitate for the indicated times (b). Changes in ER struc
Immunogold staining of calnexin was performed on ultrathin sections of cresults suggest that palmitate induces the cisternal ex-
pansion of rough ER.
Palmitate-induced cisternal ER expansion is dependent on
ER stress in RAW 264.7 cells
We initially investigated the underlying mechanism of
palmitate-induced ER expansion in RAW 264.7 cells. As
shown in Fig. 3, the ER stress markers such as phos-
phorylated PERK, BiP, CHOP, and spliced XBP-1 mRNA
were increased after treatment with palmitate in a dose-
or time- dependent manner. In addition, we examined
the effect of ER stress inhibitors, 4-PBA and TUDCA,
on the palmitate-induced cisternal ER expansion. It has
been reported that 4-PBA and TUDCA are chemical
chaperones and reduce ER stress by improving ER fold-
ing capacity and by blocking a calcium-mediated apop-
totic pathway, respectively [17, 18]. Pre-treatment withre treated with palmitate at the indicated concentration for 24 h (a)
ture were examined by transmission electron microscopy (a and b).
ryoprocessed RAW 264.7 cells (c)
Fig. 3 Palmitate induces ER stress in RAW 264.7 cells. Cells were treated with palmitate at the indicated concentration for 24 h (a and b) and
with 400 μM palmitate for the indicated times (c and d). The phosphorylation of PERK, and the expression of BiP and CHOP were determined by
western blot analysis (a and c). Total RNA was extracted and reverse transcribed to cDNA. Full-length and spliced XBP-1 cDNAs were amplified by
PCR with mouse XBP-1 primers. Gapdh cDNA was included as an internal loading control (b and d)
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of palmitate-induced ER stress (Fig. 4a and b) and cister-
nal ER expansion (Fig. 4c). These results suggest that
palmitate-induced cisternal ER expansion is dependent
on ER stress in RAW 264.7 cells.Fig. 4 Palmitate-induced cisternal ER expansion is dependent on ER stress
or 40 μM TUDCA for 1 h and followed by treatment with 400 μM palmitate
CHOP were determined by western blot analysis (a). Total RNA was extract
cDNAs were amplified by PCR with mouse XBP-1 primers. Gapdh cDNA wa
were examined by transmission electron microscopy (c)Palmitate induces phospholipid accumulation in RAW
264.7 cells
It has been reported that the increased phospholipid of
the ER membrane leads ER expansion in mouse C2C12
myoblasts [6]. We thus examined the effect of palmitatein RAW 264.7 cells. Cells were pre-treated with or without 4 mM 4-PBA
for 24 h. The phosphorylation of PERK, and the expression of BiP and
ed and reverse transcribed to cDNA. Full-length and spliced XBP-1
s included as an internal loading control (b). Changes in ER structure
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As shown in Fig. 5, phospholipid (red fluorescence)
was accumulated and distributed mainly around ER
labeled with anti-calnexin antibody (green fluorescence)
in palmitate-treated RAW 264.7 cells.
Palmitate-induced cisternal ER expansion is dependent
on the activation of XBP-1/ CCTα-mediated phospholipid
accumulation in RAW 264.7 cells
XBP-1(S), a transcription factor translated by splicing
XBP-1 mRNA, has been reported to induce the activa-
tion of choline cytidylyltransferase (CCT) α and choline
phosphotransferase (CPT), thereby increasing the syn-
thesis of phospholipid in the ER membrane, subse-
quently leading to ER expansion in NIH-3T3 fibroblasts
[12, 13]. Thus, we hypothesized that palmitate-induced
cisternal ER expansion may be mediated by XBP-1/
CCTα-mediated phospholipid accumulation. We initially
examined the effect of XBP-1 on CCTα-mediated phos-
pholipid accumulation in RAW 264.7 cells. As shown
in Fig. 6, treatment with palmitate increased the ex-
pression of CCTα at mRNA and protein levels and
the down-regulation of XBP-1 by XBP-1 siRNA trans-
fection inhibited palmitate-induced CCTα mRNA ex-
pression. In addition, the down-regulation of XBP-1
or CCTα attenuated palmitate-induced phospholipid
accumulation (Fig. 7) and cisternal ER expansion (Fig. 8).
These results suggest that palmitate induces cisternal ER
expansion via the activation of XBP-1/CCTα-mediated
phospholipid accumulation in RAW 264.7 cells.Fig. 5 Palmitate induces phospholipid accumulation in RAW 264.7 cells. Ce
24 h and then subjected to immunofluorescence using calnexin antibody a
Green fluorescence indicates calnexin or ER membrane, red fluorescence ind
of phospholipids with ER membraneTunicamycin does not induce cisternal ER expansion in
RAW 264.7 cells
We also examined the issue of whether ER stress is suffi-
cient to induce cisternal ER expansion in RAW 264.7
cells. We treated cells with tunicamycin, a well-known ER
stressor. The ER stress markers such as phosphorylated
PERK, BiP, CHOP, and spliced XBP-1 mRNA were all
increased in the tunicamycin-treated cells (Fig. 9a and b).
Although the tunicamycin treatment induced dilation
of the ER (Fig. 9c), it induced less phospholipid accumu-
lation than the palmitate treatment (Fig. 5) and no cis-
ternal ER expansion (Fig. 9c). These results suggest that
the tunicamycin-induced ER stress is not sufficient to
cause cisternal ER expansion, indicating the important
role of palmitate-induced phospholipid accumulation in
cisternal ER expansion.
Palmitate-induced cell death is not rescued by the
down-regulation of XBP-1 or CCTα in RAW 264.7 cells
It has been reported that ER stress leads ER expansion,
which, in turn, alleviates ER stress [11]. However, if ER ex-
pansion is more extended, then ER structure and integrity
are disrupted, which subsequently may lead to cell dys-
function or death. We thus examined the effect of inhib-
ition of ER expansion on palmitate-induced cell death in
RAW 264.7 cells. Pre-treatment with the ER stress inhibi-
tors, 4-PBA or TUDCA, led to an increase in cell viability
in palmitate-treated RAW 264.7 cells (Fig. 10a). However,
the down-regulation of XBP-1 by XBP-1 siRNA transfec-
tion aggravated cell death rather than protection fromlls were treated with 400 μM palmitate or 10 μg/ml tunicamycin for
nd LipidTOX Red dye to examine phospholipid accumulation in ER.
icates phospholipids and yellow fluorescence indicates co-localization
Fig. 7 Palmitate-induced phospholipid accumulation is inhibited by the dow
with control, XBP-1 or CCTα siRNAs. After 48 h transfection, the effect of XBP-
The transfected cells were treated with 400 μM palmitate for 24 h and
LipidTOX Red dye to examine phospholipid accumulation in ER. Green f
indicates phospholipids and yellow fluorescence indicates co-localization
Fig. 6 Palmitate-induced CCTα expression is dependent on XBP-1 in
RAW 264.7 cells. Cells were transfected with control or XBP-1 siRNA.
After 48 h transfection, the transfected cells were treated with
400 μM palmitate for 24 h. CCTα expression at the mRNA level was
determined by quantitative real time RT-PCR (a) and at the protein
level by western blot analysis (b). Similar results were observed in
three independent experiments. *P < 0.01 versus non-treated control
cells
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in the case of CCTα down-regulation (Fig. 10b). Although
the ER stress is responsible for palmitate-induced cell
death, these results suggest that ER expansion is not a pre-
requisite for induction of cell death in palmitate-treated
cells (Fig. 11).
Discussion
Plasma FFA levels are increased from basal levels, in the
range of 200–400 μΜ up to 800–1500 μΜ in individuals
with obesity and type 2 diabetes [19]. The concentration of
400 μΜ, at which palmitate significantly induced cisternal
ER expansion in RAW 264.7 cells, would be pathologically
relevant in patients with obesity and type 2 diabetes, since
the proportion of palmitate in FFAs is about 25 % [2] and
plasma FFAs levels increase to 800–1500 μΜ in patients
with obesity and type 2 diabetes [19].
In this study, we dissolved palmitate in NaOH/Et-OH
rather than conjugating palmitate with BSA and added
palmitate-dissolved in NaOH/Et-OH directly to the cul-
ture media to reduce the effect of endotoxins, although
the proportion of palmitate that is bound to serum albu-
min or left in an unbound state is unclear when pal-
mitate is directly added to culture media. It has been
reported that the problem of endotoxin contamination
exists even after using a low-endotoxin preparation of
BSA while preparing palmitate/BSA complexes [20]. We
also detected endotoxin contamination in palmitate-n-regulation of XBP-1 or CCTα in RAW 264.7 cells. Cells were transfected
1 or CCTα siRNA transfection was confirmed by western blot analysis (a).
then subjected to immunofluorescence using calnexin antibody and
luorescence indicates calnexin or ER membrane, red fluorescence
of phospholipids with ER membrane (b)
Fig. 8 Palmitate-induced cisternal ER expansion is attenuated by the
down-regulation of XBP-1 or CCTα in RAW 264.7 cells. Cells were
transfected with control, XBP-1 or CCTα siRNAs. After 48 h transfection,
the transfected cells were treated with 400 μM palmitate for 24 h.
Changes in ER structure were examined by transmission electron
microscopy
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tion System (GenScript, Piscataway, NJ, USA) (data not
shown). Thus, Schwartz et al. [20] recommended a new
method for preparing FFA, which we used in this study.
The ER is a continuous membrane organelle that
consists of a nuclear envelope and a peripheral network
of tubules and sheets, which make up the smooth andFig. 9 Tunicamycin does not induces cisternal ER expansion in RAW 264.7
phosphorylation of PERK, and the expression of BiP and CHOP were determ
transcribed to cDNA. Full-length and spliced XBP-1 cDNAs were amplified b
internal loading control (b). Changes in the ER structure were examined byrough ER, respectively [21]. It also serves as a principal
site for protein synthesis and folding, protein glycosyla-
tion, calcium storage and signaling, sterol biosynthesis,
and drug metabolism. Thus, the ER is sensitive to alter-
ations in calcium homeostasis and the accumulation of
misfolded proteins. The depletion of Ca2+, the inhibition
of glycosylation, exposure to chemical toxins or reactive
oxygen species, and/or the accumulation of misfolded
proteins in the ER lead to ER stress and sustained ER
stress eventually results in cell death [22]. To overcome
such ER stress, the ER responds by triggering UPR, the
ER-overload response (EOR), and ER-associated degrad-
ation (ERAD) [22].
In a branch of the UPR, the ER transmembrane kinase/
endonuclease IRE1α and β initiate a novel UPR-mediated
mRNA splicing mechanism that modifies XBP-1 transcripts
to encode a potent basic leucine zipper transcription factor,
XBP-1(S). XBP-1(S) plays an important role in phospho-
lipid synthesis in the ER membrane, especially PtdCho, by
activating the CCTα and CPT enzymes. This phospholipid
allows ER biogenesis and expansion under conditions of
ER stress in NIH-3T3 fibroblasts [12, 13]. ER expansion
through the UPR-mediated activation of lipid biosynthesis
has been reported to alleviate stress. Schuck et al. [11] re-
ported that treatment with DTT, an inhibitor of disulfide
bond formation, causes a massive expansion of the ER
through the activation of UPR signaling and the resulting
ER expansion, in turn, alleviates stress in Saccharomyces
cerevisiae. In that report, the authors suggested that the
UPR maintains ER homeostasis by providing new ER-
folding machinery and by providing additional ER surface
area and luminal space. Consistent with this result, our re-
sults also show that the inhibition of ER expansion by the
down-regulation of XBP-1 by XBP-1 siRNA transfectioncells. Cells were treated with 10 μg/ml tunicamycin for 24 h. The
ined by western blot analysis (a). Total RNA was extracted and reverse
y PCR with mouse XBP-1 primers. Gapdh cDNA was included as an
transmission electron microscopy (c)
Fig. 10 Palmitate-induced cell death is not rescued by the down-regulation of XBP-1 or CCTα in RAW 264.7 cells. Cells were pre-treated with or
without 4 mM 4-PBA or 40 μM TUDCA for 1 h and followed by treatment with 400 μM palmitate for 24 h (a). Cells were transfected with control,
XBP-1 or CCTα siRNAs. After 48 h transfection, the transfected cells were treated with 400 μM palmitate for 24 h (b). Cell viability was assessed by
an MTT assay. *P < 0.01 versus control cells
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palmitate-induced cell death (Fig. 10b) and that ER expan-
sion was frequently found in cells that survive exposure to
palmitate (Figs. 1a and 2), suggesting that ER expansion is
induced to reduce ER stress and subsequent cell death in
palmitate-treated cells (Fig. 11). Interestingly, the expansion
of the intracisternal space of ER was reported in macro-
phages residing in human atherosclerotic lesions [23]. In
atherosclerotic lesions, macrophages are recruited to the
lesions and engulf excess lipids such as saturated fatty acids
or free cholesterol, and eventually undergo ER stress.Fig. 11 A schematic diagram of the signaling pathway involved in
the palmitate-induced ER stress-mediated ER expansion in RAW
264.7 cellsHowever, if the ER stress is extended further, it then in-
duces macrophage death via UPR signaling, thereby result-
ing in necrotic core formation and plaque destabilization
[24].
In addition, ER stress is also associated with insulin re-
sistance, which is a major characteristic of metabolic dis-
eases such as obesity and type 2 diabetes. It has been
reported that ER stress inhibits insulin receptor signaling
via the promotion of the c-Jun N-terminal kinase (JNK)-
dependent serine phosphorylation of insulin receptor
substrate (IRS)-1, subsequently leading to insulin resist-
ance in mouse models of obesity [25]. Peng et al. [6] also
reported that treatment with palmitate induced ER stress
and reduced insulin-stimulated Akt phosphorylation. In
that report, the authors showed that pre-treatment with
4-PBA, an inhibitor of ER stress, efficiently reversed the
suppression of Akt phosphorylation by palmitate treat-
ment in a mouse skeletal muscle cell line, C2C12 cells,
suggesting that ER stress is a key event linking high
plasma FFA concentrations and insulin resistance in
skeletal muscle.
The findings reported herein clearly show that treatment
with 400 μΜ palmitate induced cisternal ER expansion and
ER stress in RAW 264.7 cells (Figs. 2 and 3). Diakoginnaki
et al. [5], also reported that treatment with 250 μΜ palmi-
tate induced ER stress and cisternal ER expansion in BRIN-
BD11 pancreatic β-cells. In addition, our results indicate
that the palmitate-induced ER stress-mediated activation of
XBP-1/CCTα/phospholipid accumulation is also involved
in cisternal ER expansion (Figs. 7 and 8). However,
tunicamycin-induced ER stress is not sufficient to cause
cisternal ER expansion, although the tunicamycin treat-
ment induced the splicing of XBP-1 mRNA and ER dila-
tion (Fig. 9). In addition, our results showed that the
tunicamycin treatment resulted in a lower accumulation
of phospholipid compared to the palmitate treatment
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lipid accumulation is required for cisternal ER expansion,
in addition to the activation of XBP-1/CCTα/phospholipid
accumulation.
It has been reported that palmitate induces not only
ER stress but also the direct disruption of ER structure.
Borradaile et al. [26], reported that treatment with 500
μΜ palmitate induced the generation of intracellular
reactive oxygen species (ROS), which subsequently leads
to ER stress in Chinese hamster ovary cells and H9c2
cardiomyoblasts. The authors also showed that palmitate
was directly incorporated into saturated phospholipids
and triglycerides in the ER membrane, resulting in a
dramatic dilation in the ER and subsequently cell death
in Chinese hamster ovary cells. In that report, the au-
thors suggested that the deleterious effect of palmitate
on the ER is twofold: 1) palmitate-induced ROS gener-
ation/ER stress/cell death; 2) the incorporation of palmi-
tate into the ER membrane/dramatic changes in ER
structure and integrity. It has also been reported that the
incorporation of palmitate into phospholipid, such as
PtdCho, induces detrimental stiffening of the ER mem-
brane, loss of function, and activates ER stress signaling
in rat hepatoma cell line, H4IIEC3 cells [27, 28].Conclusions
The findings reported herein indicate that palmitate in-
duces cisternal ER expansion via the activation of XBP-
1/CCTα-mediated phospholipid accumulation in RAW
264.7 cells. These findings point to a new mechanism to
explain the link between elevated levels of serum FFAs
and ER expansion in macrophages.Materials and methods
Reagents and antibodies
Palmitate, 4-phenylbutyric acid (4-PBA), tauroursodeo-
xycholic acid (TUDCA), and tunicamycin were obtained
from Sigma Aldrich Co. Ltd. (St. Louis, MO, USA).
4-PBA, TUDCA and tunicamycin were dissolved in
DMSO. The final vehicle concentration was adjusted to
0.1 % (v/v) and the control medium contained the
same quantity of vehicle. LipidTOX was obtained from
Invitrogen (Carlsbad, CA, USA). Antibodies against
phospho-PERK, PERK, BiP and the Alexa Fluor® 488-
conjugated secondary antibody were obtained from Cell
Signaling Technology (Beverly, MA, USA). Antibodies
against CHOP and calnexin were obtained from Abcam
(Cambridge, MA, USA). Antibodies against GAPDH and
horseradish peroxidase-conjugated secondary antibodies
were obtained from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). 1.4 nm gold particles conjugated sec-
ondary antibody and HQ silver enhancement kit were
obtained from Nanoprobes (Stony Brook, NY, USA).Cell culture
The RAW 264.7 murine macrophage cell line was ac-
quired from ATCC (Manassas, VA, USA) and grown as
described previously [29].
Palmitate preparation
Palmitate was prepared as described previously [20]. The
problem of endotoxin contamination still existed even
after using a low-endotoxin preparation of bovine serum
albumin (BSA) while preparing palmitate/BSA com-
plexes. Endotoxin was detected in palmitate-bound to
BSA using the ToxinSensor™ Endotoxin Detection Sys-
tem (GenScript, Piscataway, NJ, USA). To reduce endo-
toxin contamination, the palmitate was dissolved to a
final concentration of 40 mM in a solvent composed of
0.1 N NaOH/70 % ethanol and added directly to the cell
culture media, where it formed a complex with the
bovine serum albumin contained by the 10 % fetal bo-
vine serum. The control medium contained the same
quantity of the solvent. i.e., 0.1 N NaOH/70 % ethanol.
Transmission electron microscopy
Cells were fixed with 2.5 % glutaraldehyde for 2 h, post
fixed by treatment with 1 % osmium tetroxide, dehy-
drated in ethanol, and embedded in Epon 812 (Poly-
science, Warrington, PA, USA). Ultrathin ections were
contrasted with uranyl acetate and lead citrate. The
Sections were examined by transmission electron mi-
croscopy (JEOL, Arishima, Japan).
Immunogold electron microscopy
The pre-embedding immunogold-silver technique was
performed to detect the calnexin protein. The sections
(50 μm thick) were blocked with a PSG solution [0.05 %
saponin/0.2 % gelatin/0.01 M phosphate-buffered saline
(PBS)] containing 1 % bovine serum albumin and then
incubated with a calnexin antibody overnight at 4 °C.
The sections were then incubated with a secondary anti-
body conjugated with 1.4 nm gold particles for 2 h, and
silver enhancement was performed with the HQ silver
enhancement kit for 3 min. The sections were examined
by transmission electron microscopy (JEOL, Arishima,
Japan).
APOPercentage apoptosis assay
Apoptosis was detected using an APOPercentage™ kit
(Biocolor, Belfast, NIreland). Phosphatidylserine at the
outside surface of the cell membrane allows the uni-
directional transport of the APOPercentage dye to the
interior of the cell, where it is retained and accumulates
as a red-dye in apoptotic cells. The treated cells in 24-
or 96-well culture plates were stained with the APOPer-
centage dye for 1 h. The medium was then removed and
cells were washed twice with PBS. Three representative
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of APOPercentage dye uptake were quantified by the
colorimetric method according to the manufacturer’s
instructions.
Annexin V-PI staining
To investigate the mechanism associated with the death
of palmitate-treated cells, the cells were double stained
with annexin V/propidium iodide (PI), using Annexin V-
FITC Apoptosis Detection Kit (BD Pharmingen, San
Diego, CA, USA) and analyzed by flow cytometry.
Western blotting analysis
At designated times, the treated cells were removed
from the incubator and placed on ice. The cells were
then washed 3 times with ice-cold PBS. The cells were
then lysed for 30 min with RIPA lysis buffer [50 mM
Tris–HCl (pH 7.4), 1 % Triton X-100, 150 mM NaCl,
0.1 % SDS, 0.5 % sodium deoxycholate, 100 mM phenyl-
methylsulfonyl fluoride, 1 μg/ml of leupeptin, 1 mM
Na3VO4, and 1× Complete™ Protease Inhibitor Cocktail
(Santa Cruz Biotechnology, Santa Cruz, CA, USA)].
Equal amounts of protein were loaded onto 10 - 15 %
SDS-PAGE gels, electrophoresed, and transferred onto
PVDF membranes (Millipore, Bedford, MA, USA). The
membranes were blocked in Tris-Buffered Saline with
0.05 % Tween 20 (TBST) supplemented with 5 % pow-
dered milk or 5 % BSA, and then incubated with primary
antibodies against the designated proteins. The blots
were then washed with TBST and incubated with a
horseradish peroxidase-conjugated secondary antibody
in TBST plus a 5 % solution of powdered milk. The
bound antibodies were detected with Super Signal Ultra
chemiluminescence reagents (Pierce Biotechnology, Inc.,
Rockford, IL, USA).
Inhibitor treatment
Cells were plated on 6-well plates. After 24 h, the cells
were pre-treated with the designated inhibitors for 1 h,
followed by treatment with palmitate at the indicated
concentrations. After incubation for the designated
times, the cells were harvested for the next experiment.
The concentrations of inhibitors used were as follows: 4-
PBA, 4 mM and TUDCA, 40 μM. None of the inhibitors
used had a significant effect on the viability of RAW
264.7 cells.
siRNA transfection
For silencing XBP-1 and CCTα, XBP-1 and CCTα-directed
siRNA pool (ON-TARGET plus SMARTpool reagent) and
control siRNA were purchased from Dharmacon (Lafayette,
CO, USA). Cells were transfected with XBP-1, CCTα,
or control siRNA by electroporation under conditions
of a voltage of 1350 and 35 ms using a pipette typeelectroporator (MicroPorator-Mini, Disital Bio Tech-
nology, Suwon, Kyounggi-do, Korea) according to the
manufacturer’s instructions. The efficiency of XBP-1
or CCTα siRNA transfection was confirmed by west-
ern blot analysis at 48 h after transfection.
Phospholipid staining and Immunostaining
For phospholipid staining, the cells were treated with
400 μM palmitate containing 1X LipidTOX Red phos-
pholipidosis detection reagent. For Immunostaining with
an anti-calnexin antibody, the cells were fixed in 4 %
paraformaldehyde in PBS. The fixed cells were rinsed
with PBS and incubated in blocking solution (5 % goat
serum, and 0.001 % Tween-20 in TBS) for 20 min. The
cells were then incubated overnight with an anti-
calnexin antibody in an incubation solution (5 % goat
serum, and 0.1 % Tween-20 in TBS) at 4 °C. After
washing with PBS, the cells were incubated with the
corresponding Alexa Fluor® 488-conjugated secondary
antibody at room temperature for 2 h. Nuclei were
counterstained for 15 min with 10 μM Hoechst 33342
(Sigma-Aldrich Co. Ltd). The negative control was
processed without the presence of the primary antibody.
Immunofluorescence was visualized by inverted fluores-
cence microscopy (IX71/IX51, Olympus Corporation Cor-
poration, Tokyo, Japan).
RT-PCR
Total RNA was extracted using a High Pure RNA isola-
tion kit (Roche Diagnostics, Mannheim, Germany) and
converted to cDNA using an Advantage RT-for-PCR kit
(Clontech, Hampshire, UK), according to the manufac-
turer’s instructions. The cDNA was then amplified by
PCR using the forward primer XBP1s (5’-ACC TGA
GCC CGG AGG AGA AA-3’) and reverse primer
XBP1a (5’-GTC CAG AAT GCC CAA AAG GA-3’).
GAPDH RNA was amplified using the forward primer
GAPDHs (5’-GCC TTC CGT GTT CCT ACC-3’) and
the reverse primer GAPDHa (5’-CCT GCT TCA CCA
CCT TCT T-3’). PCR products were separated on a
2.5 % agarose gel.
Quantitative real time-RT-PCR
The expression of CCTα mRNA was determined by
quantitative real time-RT-PCR. Briefly, total RNA was
extracted using a High Pure RNA isolation kit (Roche
Diagnostics, Mannheim, Germany) and converted to
cDNA using an Advantage RT-for-PCR kit (Clontech,
Hampshire, UK), according to the manufacturer’s in-
structions. To quantify CCTα mRNA, quantitative real
time RT-PCR was performed with a iQTM SYBR® Super-
rmix kit (BIO-RAD Laboratories, Hercules, CA) in a
Peltier Thermal Cycler-200 system (MJ Research, Berlin,
Germany). Real time PCR was performed in triplicate at
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(94 °C for 30 s, 58 °C for 30 s, and 72 °C for 30 s). The
relative amounts of mRNA for CCTα was determined by
subtracting the cycle threshold (Ct) values for these
genes from the Ct values for Gapdh. The following
primers for CCTα and Gapdh were used: For CCTα, for-
ward primer (5’- GAT GAG CTA ACG CAC AAC TTC
AA -3’) and reverse primer (5’- GTG CTG CAC GGC
GTC ATA -3’). For Gapdh, forward primer (5’-GGG
AAG CTC ACT GGC ATG G-3’) and reverse primer
(5’-CTT CTT GAT GTC ATC ATA CTT GGC AG-3’).
Cell viability assay
Cell viability was evaluated by an MTT [3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide] reduction
assay in 96-well plates. At designated times, 10 μL of
50 mg/mL MTT solution was added to each well. After
incubation in a 5 % CO2 incubator for 2 h at 37 °C, the
media was removed and 100 μL of acid isopropyl alcohol
was added to each well. After 10 min incubation, 100 μL
of distilled water was added to each well and the optical
density of each well was then measured at 570 nm with
a spectrometer (μ-Quant, Bio-tech instrument, Inc.,
Winooski, VT).
Statistical analysis
All results are expressed as the means ± S.D. of data from
at least three separate experiments. Statistical significance
was determined via the Student’s t-test for two points.
p < 0.01 was considered to be statistically significant.
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